Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Mikihiro Kusama"'
Autor:
Keisei, Anan, Shoshu, Mitsuyama, Yasuhiro, Yanagita, Morihiko, Kimura, Hiroyoshi, Doihara, Kansei, Komaki, Mikihiro, Kusama, Tadashi, Ikeda
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 45(12)
The criteria for biological postmenopause have not been clearly defined, although determining the menopausal status is crucial for selecting agents for adjuvant endocrine therapy for patients with breast cancer. The long-term effects of adjuvant tore
Autor:
Shoshu Mitsuyama, Yasuhiro Yanagita, Nobuaki Sato, Kansei Komaki, Tomomi Fujisawa, Keisuke Miyauchi, Tadashi Ikeda, Keisei Anan, Hiromitsu Jinno, Morihiko Kimura, Hiroyoshi Doihara, Mikihiro Kusama, Tadahiko Shien, Chizuko Kanbayashi, Muneaki Sano
Publikováno v:
Cancer Chemotherapy and Pharmacology
A prospective randomized phase II trial was conducted to evaluate the time course effects of toremifene (TOR) and letrozole (LET), as adjuvant hormone therapy, on serum lipid profiles and bone metabolism in estrogen receptor (ER)-positive, postmenopa
Autor:
Morihiko Kimura, Tadashi Ikeda, Hiroyoshi Doihara, Shoshu Mitsuyama, Keisei Anan, Kansei Komaki, Mikihiro Kusama, Yasuhiro Yanagita
Publikováno v:
Breast Cancer Research and Treatment. 128:775-781
The potential long-term adverse effects on quality of life have to be considered when selecting agents for adjuvant hormonal treatment for postmenopausal patients with estrogen receptor-positive breast cancer. We performed a 2-year multicenter random
Autor:
Toshio Tabei, Kazushige Toyama, Masataka Yoshimoto, Shigeto Miura, Eisei Shin, Tadashi Nomizu, Mikihiro Kusama, Shinzaburo Noguchi, Noboru Horikoshi, Morihiko Kimura, Kenjiro Aogi, N. Yoshimura
Publikováno v:
Breast Cancer. 17:233-240
A multicenter, phase II study was conducted to evaluate the efficacy and safety of the Japanese intermittent 4-week regimen of capecitabine in patients with advanced/metastatic breast cancer.Fifty patients who had received no more than one prior chem
Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer
Autor:
Takayuki Kinoshita, Masataka Yoshimoto, Tadashi Ikeda, Yoshifumi Komoike, Hideo Inaji, Reiki Nishimura, Tsunehiro Nishi, Eisei Shin, Hiroshi Sonoo, Sadako Akashi-Tanaka, Shigeru Murakami, Keiichi Mise, Hideaki Tsukuma, Futoshi Akiyama, Yuichi Iino, Shozo Ohsumi, Kimito Suemasu, Mikihiro Kusama, Tetsuya Taguchi, Muneaki Sano, Shunsuke Haga
Publikováno v:
Cancer. 106:35-41
BACKGROUND The clinical features of ipsilateral breast tumor recurrence (IBTR) after breast conserving therapy (BCT) for early stage breast cancer were analyzed from long-term follow-up of BCT in Japan. The purpose of this study was to clarify risk f
Autor:
Shozo Ohsumi, Reiki Nishimura, Tunehiro Nishi, Takayuki Kinoshita, Keiichi Mise, Shigeru Murakami, Muneaki Sano, Masataka Yoshimoto, Hiroshi Sonoo, Yuichi Iino, Yoshifumi Komoike, Hideo Inaji, Shunsuke Haga, Hideaki Tsukuma, Kimito Suemasu, Futoshi Akiyama, Mikihiro Kusama, Sadako Tanaka-Akashi, Tadashi Ikeda, Tetsuya Taguchi, Eisei Shin
Publikováno v:
Breast Cancer. 12:104-111
Ipsilateral breast tumor recurrences (IBTR) after breast-conserving treatment include two different entities: true recurrence (TR) thought to occur when residual cancer cells grow gradually to detectable size and new primary (NP) thought to be de nov
Autor:
Morihiko Kimura, Mikihiro Kusama, K. Miyauchi, Muneaki Sano, Hiroyoshi Doihara, Shoshu Mitsuyama, Kansei Komaki, H. Aoyama
Publikováno v:
Breast Cancer Research and Treatment. 88:1-8
This study clarified the difference in the effects on serum lipids between toremifene (TOR) and tamoxifen (TAM). To remove influencing factors, we investigated adjuvant therapy for hormone receptor-positive patients with breast cancer without lymph n
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 64:1468-1472
症例は76歳の男性で,外傷の既往なくショックを伴った腹部全体の疼痛にて緊急入院した.この患者は9カ月前にも原因不明の脾破裂による腹腔内出血のため入院し,このときは保存的に軽快
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 64:940-944
原発性虫垂癌は,切除した虫垂の0.01~0.19%を占める比較的稀な疾患であり,その約半数は粘液嚢胞腺癌である.この疾患は遠隔転移やリンパ行性転移は稀とされている.今回,胆嚢転移を生じ
Autor:
Nariaki Matsuura, Takayoshi Uematsu, Takanori Ishida, Yasuhiro Tamaki, Sadako Akashi-Tanaka, Seigo Nakamura, Yuka Sawai, Yoshinobu Sato, Mikihiro Kusama, Y. Tanji, K. Hisamatsu
Publikováno v:
Breast Cancer. 9:289-295
To perform optimal tumor resection of breast cancer, preoperative information concerning intraductal spread of cancer (ISC) is very important.To detect ISC, three-dimensional (3D) imaging methods including helical CT, MRI, and ultrasound were examine